↓ Skip to main content

Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?

Overview of attention for article published in Orphanet Journal of Rare Diseases, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
Published in
Orphanet Journal of Rare Diseases, February 2022
DOI 10.1186/s13023-022-02236-6
Pubmed ID
Authors

Alice Bruscolini, Marco Marenco, Giuseppe Maria Albanese, Alessandro Lambiase, Marta Sacchetti

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 33%
Professor 2 13%
Lecturer 1 7%
Student > Doctoral Student 1 7%
Unknown 6 40%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 13%
Nursing and Health Professions 2 13%
Neuroscience 2 13%
Medicine and Dentistry 2 13%
Biochemistry, Genetics and Molecular Biology 1 7%
Other 0 0%
Unknown 6 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2022.
All research outputs
#15,053,192
of 23,164,913 outputs
Outputs from Orphanet Journal of Rare Diseases
#1,732
of 2,654 outputs
Outputs of similar age
#232,697
of 437,826 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#69
of 137 outputs
Altmetric has tracked 23,164,913 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,654 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,826 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 137 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.